| Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-38,896 | -36,862 | 0 | 0 | 0 | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
301 | 276 | 0 | 0 | 0 | ||
Non-cash share-based compensation | ||||||
5,079 | 4,181 | 0 | 0 | 0 | ||
Accretion on marketable securities | ||||||
0 | - | - | - | - | ||
Deferred taxes | ||||||
0 | - | - | - | - | ||
Unrealized foreign currency (gains) losses | ||||||
5,034 | 389 | 0 | 0 | 0 | ||
Realized investment (gains) losses | ||||||
0 | - | - | - | - | ||
Changes in operating assets and liabilities: | ||||||
Research and development tax credit receivable | ||||||
0 | - | - | - | 0 | ||
Prepaid expenses and other assets | ||||||
3,271 | 3,256 | 0 | 0 | 0 | ||
Accounts payable | ||||||
-1,758 | -9 | 0 | 0 | 0 | ||
Accrued expenses and other liabilities | ||||||
11,414 | 5,633 | 0 | 0 | 0 | ||
Net cash used in operating activities | ||||||
-48,072 | -45,632 | 0 | 0 | 0 | ||
Cash flows from investing activities: | ||||||
Proceeds from maturities of marketable securities | ||||||
0 | - | - | - | - | ||
Purchases of property and equipment | ||||||
680 | 709 | 0 | 0 | 0 | ||
Net cash provided by (used in) investing activities | ||||||
-57,970 | -135,999 | 0 | 0 | 0 | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
1,172 | 2,905 | 0 | 0 | 0 | ||
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||
-27,706 | -101,562 | 0 | 0 | 0 | ||